MXPA01007833A - Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria. - Google Patents
Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria.Info
- Publication number
- MXPA01007833A MXPA01007833A MXPA01007833A MXPA01007833A MXPA01007833A MX PA01007833 A MXPA01007833 A MX PA01007833A MX PA01007833 A MXPA01007833 A MX PA01007833A MX PA01007833 A MXPA01007833 A MX PA01007833A MX PA01007833 A MXPA01007833 A MX PA01007833A
- Authority
- MX
- Mexico
- Prior art keywords
- coronary artery
- intervention
- pharmaceutically acceptable
- acceptable salt
- composition according
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11846399P | 1999-02-03 | 1999-02-03 | |
| PCT/US2000/002611 WO2000045810A1 (en) | 1999-02-03 | 2000-02-02 | Method for the prevention or reduction of cardiovascular events associated with coronary intervention |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA01007833A true MXPA01007833A (es) | 2002-06-21 |
Family
ID=22378760
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA01007833A MXPA01007833A (es) | 1999-02-03 | 2000-02-02 | Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria. |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1180027A4 (ko) |
| JP (1) | JP2002536326A (ko) |
| KR (1) | KR20010101933A (ko) |
| CN (1) | CN1338930A (ko) |
| AR (1) | AR022475A1 (ko) |
| AU (1) | AU2978500A (ko) |
| BR (1) | BR0007901A (ko) |
| CA (1) | CA2361578A1 (ko) |
| CO (1) | CO5160246A1 (ko) |
| HU (1) | HUP0200148A3 (ko) |
| IL (1) | IL144719A0 (ko) |
| MX (1) | MXPA01007833A (ko) |
| NO (1) | NO20013789L (ko) |
| PL (1) | PL349926A1 (ko) |
| TR (1) | TR200102262T2 (ko) |
| WO (1) | WO2000045810A1 (ko) |
| ZA (1) | ZA200106297B (ko) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8097650B2 (en) * | 2005-07-27 | 2012-01-17 | The Trustees Of Columbia University In The City Of New York | Method of treating a condition associated with phosphorylation of TASK-1 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617407B2 (ja) * | 1992-09-14 | 1997-06-04 | キッセイ薬品工業株式会社 | 血管内膜細胞過剰増殖疾患の予防および治療剤 |
| EP0855387A4 (en) * | 1995-09-07 | 1999-09-15 | Kissei Pharmaceutical | 2-ACYLAMINOBENZAMIDE DERIVATIVES, PREVENTIVE AND REMEDY AGAINST DISEASES CAUSED BY OVERMULTIPLICATION OF INTIMA VASCULAR CELLS |
| US6019104A (en) * | 1996-12-30 | 2000-02-01 | Kissei Pharmaceutical Co., Ltd. | Method for the treatment or prevention of restenosis associated with coronary intervention |
-
2000
- 2000-02-02 TR TR2001/02262T patent/TR200102262T2/xx unknown
- 2000-02-02 EP EP00908440A patent/EP1180027A4/en not_active Withdrawn
- 2000-02-02 BR BR0007901-4A patent/BR0007901A/pt not_active Application Discontinuation
- 2000-02-02 AU AU29785/00A patent/AU2978500A/en not_active Abandoned
- 2000-02-02 AR ARP000100437A patent/AR022475A1/es unknown
- 2000-02-02 MX MXPA01007833A patent/MXPA01007833A/es unknown
- 2000-02-02 KR KR1020017009743A patent/KR20010101933A/ko not_active Application Discontinuation
- 2000-02-02 HU HU0200148A patent/HUP0200148A3/hu unknown
- 2000-02-02 JP JP2000596930A patent/JP2002536326A/ja not_active Withdrawn
- 2000-02-02 IL IL14471900A patent/IL144719A0/xx unknown
- 2000-02-02 WO PCT/US2000/002611 patent/WO2000045810A1/en not_active Application Discontinuation
- 2000-02-02 PL PL00349926A patent/PL349926A1/xx not_active Application Discontinuation
- 2000-02-02 CA CA002361578A patent/CA2361578A1/en not_active Abandoned
- 2000-02-02 CN CN00803386A patent/CN1338930A/zh active Pending
- 2000-02-03 CO CO00006605A patent/CO5160246A1/es unknown
-
2001
- 2001-07-31 ZA ZA200106297A patent/ZA200106297B/en unknown
- 2001-08-02 NO NO20013789A patent/NO20013789L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CA2361578A1 (en) | 2000-08-10 |
| NO20013789D0 (no) | 2001-08-02 |
| EP1180027A4 (en) | 2004-11-17 |
| CN1338930A (zh) | 2002-03-06 |
| CO5160246A1 (es) | 2002-05-30 |
| KR20010101933A (ko) | 2001-11-15 |
| PL349926A1 (en) | 2002-10-21 |
| IL144719A0 (en) | 2002-06-30 |
| TR200102262T2 (tr) | 2002-02-21 |
| HUP0200148A2 (hu) | 2002-05-29 |
| EP1180027A1 (en) | 2002-02-20 |
| AR022475A1 (es) | 2002-09-04 |
| HUP0200148A3 (en) | 2003-06-30 |
| AU2978500A (en) | 2000-08-25 |
| JP2002536326A (ja) | 2002-10-29 |
| BR0007901A (pt) | 2001-10-30 |
| WO2000045810A1 (en) | 2000-08-10 |
| ZA200106297B (en) | 2002-07-31 |
| NO20013789L (no) | 2001-09-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2106172C (en) | Use of 2-(3,4-dimethoxycinnamoyl)aminobenzoic acid for the treatment of restenosis associated with coronary intervention | |
| TW389696B (en) | Accelerated release composition containing bromocriptine | |
| JP2505944B2 (ja) | （Ｓ）―α―フルオロメチル―ヒスチジン及びそのエステルを含有するぜん息治療用医薬組成物 | |
| US20080058303A1 (en) | Use of melagatran | |
| EP1035854A1 (en) | Use of alpha-glucosidase inhibitors for treating high-risk impaired glucose tolerance | |
| HU202754B (en) | Process for producing flavoxate derivatives and pharmaceutical compositions containing them as active components | |
| AU9160198A (en) | A pharmaceutical composition active in reducing production of mcp-1 protein | |
| AU2007234917B2 (en) | Renin inhibitors for the treatment of hypertension | |
| MXPA01007833A (es) | Metodo para prevenir o reducir eventos cardiovasculares asociados con intervencion de la arteria coronaria. | |
| KR20010105418A (ko) | 기분 장애 치료용 오사네턴트 | |
| JP2001526217A (ja) | 血管性頭痛に対する局所麻酔薬の新規な使用 | |
| JPH0564124B2 (ko) | ||
| KR20010101934A (ko) | 관상혈관 시술과 관련된 심혈관 사건의 예방 및 감소 방법 | |
| WO2001097798A1 (en) | Method for the prevention or reduction of cardiovascular events associated with coronary intervention | |
| JPH09227371A (ja) | 粥状動脈硬化抑制剤 | |
| CN117243948A (zh) | 包含瑞香素的组合物在制备风湿性关节炎药物中的应用 | |
| JP2002514208A (ja) | 痴呆の治療及び予防におけるシクロオキシゲナーゼ−２阻害剤の使用方法 | |
| WO1999007412A1 (fr) | Remedes contre les maladies associees a la resorption osseuse | |
| MXPA01007003A (es) | Nuevo uso del melagatran | |
| WO1997000072A1 (fr) | Composition anti-inflammatoire/analgesique | |
| WO2000074678A1 (fr) | Analgesique |